Customized research for ARPO vs. IMGN!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for ARPO vs. IMGN.


↗ Join Our Free Email Newsletter.




Aerpio Pharmaceuticals Inc. vs. ImmunoGen, Inc.

Industry Match! Industry of Both ARPO and IMGN:

Health Care/Life Sciences

ARPO
Data Last Updated: 5 days ago

↻  Update Column 1 to Most Recent

Key Statistics

Cap: 38.964M


P/E: N/A

P/S: 1.93

Q P/B: 0.77

Y Rev: 20.16M

Q Rev: -

Beta: N/A

ARPO Share Stats

Outstanding Shares

40.59M

Float Shares

28.06M

Percent of Float Short

0.44%

ARPO Insider Stats

Percent Outstanding Insider Ownership

N/A

Percent Outstanding Institution Ownership

N/A

ARPO Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

ARPO in Pulse Portal

Stream of Posts

ARPO Symbol Page

Share ARPO Insights

Express Sentiment

'Buy' or 'Sell' ARPO

ARPO Profile

CEO

Mr. Muneer A. Satter

Exchange

Nasdaq

Employees

27.00

About

Aerpio Pharmaceuticals Inc. is a biopharmaceutical company, which engages in the research and development of treatments for ocular diseases. Its product candidate is AKB-9778, a small molecule activator of the Tie2 pathway, which completed the Phase 2a clinical trial...

ARPO Financials

Annual Financials

Income Statement

Revenue

20.16M

Net Income

(10.4M)

Cash Flow Statement

Change in Cash / Investments

42.35M

Balance Sheet

Cash / Investments

62.61M

Short Term Debt

None

Long Term Debt

None

Total Current Assets

63.98M

Total Current Liabilities

5.46M

Total Assets

64.12M

Total Liabilities

5.46M

Stockholder Equity

58.67M

Quarterly Financials

Income Statement

Q Revenue

-

Q Net Income

(8.49M)

Cash Flow Statement

Q Change in Cash / Investments

(9.19M)

Balance Sheet

Q Cash / Investments

53.42M

Q Short Term Debt

189,511

Q Long Term Debt

None

Q Total Current Assets

54.3M

Q Total Current Liabilities

3.92M

Q Total Assets

55.06M

Q Total Liabilities

4.26M

Q Stockholder Equity

50.8M

ARPO Charts

10-Year Chart

ARPO 10-Year Chart

5-Year Chart

ARPO 5-Year Chart

1-Year Chart

ARPO 1-Year Chart

6-Month Chart

ARPO 6-Month Chart

3-Month Chart

ARPO 3-Month Chart

1-Month Chart

ARPO 1-Month Chart

1-Day Chart

ARPO 1-Day Chart

IMGN
Data Last Updated: 5 days ago

↻  Update Column 2 to Most Recent

Key Statistics

Cap: 321.492M


P/E: N/A

P/S: 6.01

Q P/B: N/A

Y Rev: 53.45M

Q Rev: 8.58M

Beta: 2.31

IMGN Share Stats

Outstanding Shares

149.53M

Float Shares

146.45M

Percent of Float Short

7.58%

IMGN Insider Stats

Percent Outstanding Insider Ownership

N/A

Percent Outstanding Institution Ownership

N/A

IMGN Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

IMGN in Pulse Portal

Stream of Posts

IMGN Symbol Page

Share IMGN Insights

Express Sentiment

'Buy' or 'Sell' IMGN

IMGN Profile

CEO

Mr. Mark J. Enyedy

Exchange

Nasdaq

Employees

296.00

About

ImmunoGen, Inc. is a biotechnology company, which engages in discovering and developing antibody-drug conjugate therapies that meaningfully improve the lives of people with cancer. Its product candidates include Mirvetuximab soravtansine, Coltuximab ravtansine, IMGN7779...

IMGN Financials

Annual Financials

Income Statement

Revenue

53.45M

Net Income

(168.84M)

Cash Flow Statement

Change in Cash / Investments

(4.86M)

Balance Sheet

Cash / Investments

262.25M

Short Term Debt

None

Long Term Debt

124.41M

Total Current Assets

278.78M

Total Current Liabilities

70.66M

Total Assets

295.38M

Total Liabilities

284.41M

Stockholder Equity

10.97M

Quarterly Financials

Income Statement

Q Revenue

8.58M

Q Net Income

(43.75M)

Cash Flow Statement

Q Change in Cash / Investments

8.14M

Balance Sheet

Q Cash / Investments

270.4M

Q Short Term Debt

2.63M

Q Long Term Debt

119.85M

Q Total Current Assets

289.84M

Q Total Current Liabilities

61.43M

Q Total Assets

323.93M

Q Total Liabilities

351.53M

Q Stockholder Equity

(27.6M)

IMGN Charts

10-Year Chart

IMGN 10-Year Chart

5-Year Chart

IMGN 5-Year Chart

1-Year Chart

IMGN 1-Year Chart

6-Month Chart

IMGN 6-Month Chart

3-Month Chart

IMGN 3-Month Chart

1-Month Chart

IMGN 1-Month Chart

1-Day Chart

IMGN 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon